These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33645485)

  • 1. Medication Adherence of Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis Considering the Psychosocial Factors, Health Literacy and Current Life Concerns of Patients.
    Shenavandeh S; Mani A; Eazadnegahdar M; Nekooeian A
    Curr Rheumatol Rev; 2021; 17(4):412-420. PubMed ID: 33645485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Psychosocial and Neuropsychiatric Factors on Medication Adherence in a Cohort of Women With Systemic Lupus Erythematosus.
    Flower C; Hambleton I; Campbell M
    J Clin Rheumatol; 2016 Dec; 22(8):411-417. PubMed ID: 27870763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health care and burden of illness in systemic lupus erythematosus compared to rheumatoid arthritis: results from the National Database of the German Collaborative Arthritis Centres.
    Zink A; Fischer-Betz R; Thiele K; Listing J; Huscher D; Gromnica-Ihle E; Specker C; Schneider M;
    Lupus; 2004; 13(7):529-36. PubMed ID: 15352425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication adherence, depression and disease activity among patients with systemic lupus erythematosus.
    Alsowaida N; Alrasheed M; Mayet A; Alsuwaida A; Omair MA
    Lupus; 2018 Feb; 27(2):327-332. PubMed ID: 28825347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-conception status, obstetric outcome and use of medications during pregnancy of systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and inflammatory bowel disease (IBD) in Japan: Multi-center retrospective descriptive study.
    Tsuda S; Sameshima A; Sekine M; Kawaguchi H; Fujita D; Makino S; Morinobu A; Murakawa Y; Matsui K; Sugiyama T; Watanabe M; Suzuki Y; Nagahori M; Murashima A; Atsumi T; Oku K; Mitsuda N; Takei S; Miyamae T; Takahashi N; Nakajima K; Saito S;
    Mod Rheumatol; 2020 Sep; 30(5):852-861. PubMed ID: 31483178
    [No Abstract]   [Full Text] [Related]  

  • 6. Trust in the attending rheumatologist, health-related hope and medication adherence among Japanese systemic lupus erythematosus patients.
    Kurita N; Oguro N; Miyawaki Y; Hidekawa C; Sakurai N; Ichikawa T; Ishikawa Y; Hayashi K; Shidahara K; Kishida D; Yoshimi R; Sada KE; Shimojima Y; Yajima N
    Rheumatology (Oxford); 2023 Jun; 62(6):2147-2153. PubMed ID: 36190334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment adherence in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Garcia-Gonzalez A; Richardson M; Garcia Popa-Lisseanu M; Cox V; Kallen MA; Janssen N; Ng B; Marcus DM; Reveille JD; Suarez-Almazor ME
    Clin Rheumatol; 2008 Jul; 27(7):883-9. PubMed ID: 18185905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depressive Symptoms Are Associated With Low Treatment Adherence in African American Individuals With Systemic Lupus Erythematosus.
    Heiman E; Lim SS; Bao G; Drenkard C
    J Clin Rheumatol; 2018 Oct; 24(7):368-374. PubMed ID: 29912774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medication adherence in patients with rheumatoid arthritis: why do patients not take what we prescribe?
    Wong PK
    Rheumatol Int; 2016 Nov; 36(11):1535-1542. PubMed ID: 27665289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of health literacy and its association with medication adherence and quality of life in childhood-onset systemic lupus erythematosus.
    Vater M; Davis A; Jaser S
    Lupus; 2024 Aug; 33(9):1004-1011. PubMed ID: 38830236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Duality of Economic Issues With Medication Non-adherence in Patients With Inflammatory Arthritis.
    Campbell NKJ; Saadeldin K; De Vera MA
    Curr Rheumatol Rep; 2017 Sep; 19(10):66. PubMed ID: 28921409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties of SBI-087, a CD20-Directed B-cell Depleting Agent: Phase 1 Dose Escalating Studies in Patients With Either Mild Rheumatoid Arthritis or Systemic Lupus.
    Cohen S; Clowse M; Pardo P; Bhattacharya I; Menon S; Gourley I; Diehl A
    Clin Ther; 2016 Jun; 38(6):1417-1434.e2. PubMed ID: 27112532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychiatric syndromes in patients with systemic lupus erythematosus and rheumatoid arthritis.
    Hanly JG; Fisk JD; McCurdy G; Fougere L; Douglas JA
    J Rheumatol; 2005 Aug; 32(8):1459-6. PubMed ID: 16078320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication Adherence in Chinese Patients With Systemic Lupus Erythematosus.
    Du X; Chen H; Zhuang Y; Zhao Q; Shen B
    J Clin Rheumatol; 2020 Apr; 26(3):94-98. PubMed ID: 30601165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of treatments on cell adhesion molecules in patients with systemic lupus erythematosus and rheumatoid arthritis: a review.
    da Rosa Franchi Santos LF; Costa NT; Maes M; Simão ANC; Dichi I
    Inflammopharmacology; 2020 Apr; 28(2):363-384. PubMed ID: 31820195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication adherence in patients in treatment for rheumatoid arthritis and systemic lupus erythematosus in a university hospital in Brazil.
    Prudente LR; Diniz Jde S; Ferreira TX; Lima DM; Silva NA; Saraiva G; Silveira EA; Dewulf Nde L; Amaral RG
    Patient Prefer Adherence; 2016; 10():863-70. PubMed ID: 27279735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of common susceptibility genes and drug target genes in multiple sclerosis, systemic lupus erythematosus, and rheumatoid arthritis and its value to guide clinical treatment.
    Liu Y; Rang X; Zou X; Wang X; Zhang X; Wang Y; Xu C; Fu J
    Mult Scler Relat Disord; 2022 Feb; 58():103504. PubMed ID: 35030369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of treatment adherence in ethnically diverse, economically disadvantaged patients with rheumatic disease.
    Garcia Popa-Lisseanu MG; Greisinger A; Richardson M; O'Malley KJ; Janssen NM; Marcus DM; Tagore J; Suarez-Almazor ME
    J Rheumatol; 2005 May; 32(5):913-9. PubMed ID: 15868630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study on clinical and serological characteristics between patients with rhupus and those with systemic lupus erythematosus and rheumatoid arthritis.
    Frade-Sosa B; Narváez J; Salman-Monte TC; Castellanos-Moreira R; Ortiz-Santamaria V; Torrente-Segarra V; Castellvi I; Magallares B; Reina D; Minguez S; Sallés M; Manrique de Lara MG; Ordoñez S; Riera E; Schur PH; Gómez-Puerta JA
    Lupus; 2020 Sep; 29(10):1216-1226. PubMed ID: 32631205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased circulating CXCL13 levels in systemic lupus erythematosus and rheumatoid arthritis: a meta-analysis.
    Bao YQ; Wang JP; Dai ZW; Mao YM; Wu J; Guo HS; Xia YR; Ye DQ
    Clin Rheumatol; 2020 Jan; 39(1):281-290. PubMed ID: 31523787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.